- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
B&L Foundation funds $2.5M engineering chair
Rochester, NY—The Bausch & Lomb Foundation has donated $2.5 million to the Rochester Institute of Technology (RIT) to fund the Bausch & Lomb Endowed Chair in Microsystems Engineering in the institute's Kate Gleason College of Engineering.
Rochester, NY-The Bausch & Lomb Foundation has donated $2.5 million to the Rochester Institute of Technology (RIT) to fund the Bausch & Lomb Endowed Chair in Microsystems Engineering in the institute's Kate Gleason College of Engineering.
Several research programs being jointly developed by Bausch & Lomb and RIT could involve additional funding of $2.5 million over the next 5 years. The research will delve into potential therapeutic and diagnostic technology to address ocular diseases and conditions. Projects being considered include advanced microsystems and technologies to diagnose, monitor, and treat eye disease; the development of biodegradable devices for sustained drug delivery to the eye; and accommodating IOLs to provide presbyopic vision correction for patients with cataracts.
